Tower View Wealth Management’s Precigen PGEN Stock Holding History

Tower View Wealth Management’s Portfolio PGEN Stock Details PGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-83	Closed	-$1K	–	232
2021 Q2	$1K	Hold	83	–	–	﹤0.01%	169
2021 Q1	$1K	Hold	83	–	–	﹤0.01%	184
2020 Q4	$1K	Hold	83	–	–	﹤0.01%	171
2020 Q3	$0	Hold	83	–	–	﹤0.01%	161
2020 Q2	$0	Hold	83	–	–	﹤0.01%	155
2020 Q1	$0	Hold	83	–	–	﹤0.01%	132
2019 Q4	$0	Hold	83	–	–	﹤0.01%	145
2019 Q3	$0	Hold	83	–	–	﹤0.01%	142
2019 Q2	$1K	Hold	83	–	–	﹤0.01%	133
2019 Q1	$0	Hold	83	–	–	﹤0.01%	146
2018 Q4	$1K	Hold	83	–	–	﹤0.01%	135
2018 Q3	$1K	Hold	83	–	–	﹤0.01%	158
2018 Q2	$1K	Hold	83	–	–	﹤0.01%	142
2018 Q1	$1K	Hold	83	–	–	﹤0.01%	135
2017 Q4	$1K	Buy	+83	New	+$1.24K	﹤0.01%	143

Other funds holding PGEN

Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Tower View Wealth Management's PGEN Position: Q3 2021 in Review

Tower View Wealth Management sold out of Precigen (PGEN) in Q3 2021, closing a stake of 83 shares — an estimated $1K sold.

Tower View Wealth Management first reported a position in PGEN in Q4 2017 and held it in 15 quarters. The position peaked at $1K in Q2 2021. 172 funds tracked by Wall St. Rank hold PGEN as of Q3 2021.

Tower View Wealth Management reported no remaining Precigen position as of Q3 2021 after selling out during the quarter.
Tower View Wealth Management sold 83 Precigen shares in Q3 2021, an estimated $1K.
Tower View Wealth Management first reported a position in Precigen in Q4 2017 and held it in 15 quarters.
Tower View Wealth Management's Precigen position peaked at $1K in Q2 2021.
172 funds tracked by Wall St. Rank held Precigen as of Q3 2021.

Based on Tower View Wealth Management's 13F filing for Q3 2021, filed 8 Nov 2021.